Adaptimmune Therapeutics ADAPY Earnings Call Transcripts

OTC ADAPY
$0.02 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST
5 earnings calls on file for Adaptimmune Therapeutics, from Q1 2020 to Q3 2021. Each transcript opens in a new tab.
Latest earnings call

Adaptimmune Therapeutics Q3 2021 Earnings Call

Nov 4, 2021 3,739 words · 16 min read
  • Juli P. MillerSenior Director of Investor Relations
  • Adrian G. RawcliffeChief Executive Officer, Principal Accounting Officer & Director
  • Elliot NorryChief Medical Officer
  • John LungerChief Patient Supply Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Adaptimmune Therapeutics Earnings Call Transcripts

Calls5
LatestNov 4, 2021
SinceQ1 2020

Fiscal 2021

Fiscal 2020

All 5 Adaptimmune Therapeutics transcripts Register to get access to Adaptimmune Therapeutics’s earnings call transcripts.